Are contraindications for Extra Super Zhewitra users?
Verfasst: Do 4. Apr 2024, 07:39Extra Super Zhewitra is a medication used to treat both erectile dysfunction (ED) and premature ejaculation (PE) in men. It contains two active ingredients: vardenafil (20 mg) and dapoxetine (60 mg). As with any medication, there are certain contraindications for its use. Here are some contraindications for users of Extra Super Zhewitra:
Allergy or Hypersensitivity: Individuals who have a known allergy or hypersensitivity to vardenafil, dapoxetine, or any other ingredients in Extra Super Zhewitra should not use this medication. Allergic reactions can range from mild skin rashes to severe anaphylaxis and require immediate medical attention.
Nitrate Medications: Extra Super Zhewitra should not be used concomitantly with nitrates or nitric oxide donors, such as nitroglycerin. The combination of vardenafil and nitrates can lead to a significant drop in blood pressure, which may result in dizziness, fainting, or even life-threatening cardiovascular events.
Severe Cardiovascular Disorders: Individuals with severe cardiovascular disorders, such as unstable angina, severe heart failure, or uncontrolled hypertension, are generally advised against using Extra Super Zhewitra. The medication can exert cardiovascular effects, including vasodilation and changes in blood pressure, which may exacerbate underlying cardiovascular conditions.
Severe Liver or Kidney Impairment: Extra Super Zhewitra should be used with caution in individuals with severe liver or kidney impairment. Both vardenafil and dapoxetine are metabolized primarily in the liver and excreted through the kidneys. Impaired liver or kidney function can affect the metabolism and elimination of these drugs, leading to higher drug levels and an increased risk of adverse effects.
Certain Eye Disorders: Extra Super Zhewitra should be used with caution in individuals with certain eye disorders, such as retinitis pigmentosa or non-arteritic anterior ischemic optic neuropathy (NAION). There have been rare reports of vision loss associated with the use of PDE5 inhibitors like vardenafil. Individuals with these conditions should discuss the risks and benefits of Extra Super Zhewitra with their healthcare provider.
Combination with Other ED or PE Medications: Extra Super Zhewitra should not be used concomitantly with other medications used to treat erectile dysfunction or premature ejaculation, including other PDE5 inhibitors or selective serotonin reuptake inhibitors (SSRIs). Combining these medications can increase the risk of side effects and adverse reactions.
It's important to note that this list is not exhaustive, and there may be other contraindications or precautions for the use of Extra Super Zhewitra. Individuals considering using this medication should consult with their healthcare provider to discuss their medical history and any potential risks or concerns before starting treatment. Your healthcare provider can provide personalized guidance and recommendations based on your individual circumstances.
Allergy or Hypersensitivity: Individuals who have a known allergy or hypersensitivity to vardenafil, dapoxetine, or any other ingredients in Extra Super Zhewitra should not use this medication. Allergic reactions can range from mild skin rashes to severe anaphylaxis and require immediate medical attention.
Nitrate Medications: Extra Super Zhewitra should not be used concomitantly with nitrates or nitric oxide donors, such as nitroglycerin. The combination of vardenafil and nitrates can lead to a significant drop in blood pressure, which may result in dizziness, fainting, or even life-threatening cardiovascular events.
Severe Cardiovascular Disorders: Individuals with severe cardiovascular disorders, such as unstable angina, severe heart failure, or uncontrolled hypertension, are generally advised against using Extra Super Zhewitra. The medication can exert cardiovascular effects, including vasodilation and changes in blood pressure, which may exacerbate underlying cardiovascular conditions.
Severe Liver or Kidney Impairment: Extra Super Zhewitra should be used with caution in individuals with severe liver or kidney impairment. Both vardenafil and dapoxetine are metabolized primarily in the liver and excreted through the kidneys. Impaired liver or kidney function can affect the metabolism and elimination of these drugs, leading to higher drug levels and an increased risk of adverse effects.
Certain Eye Disorders: Extra Super Zhewitra should be used with caution in individuals with certain eye disorders, such as retinitis pigmentosa or non-arteritic anterior ischemic optic neuropathy (NAION). There have been rare reports of vision loss associated with the use of PDE5 inhibitors like vardenafil. Individuals with these conditions should discuss the risks and benefits of Extra Super Zhewitra with their healthcare provider.
Combination with Other ED or PE Medications: Extra Super Zhewitra should not be used concomitantly with other medications used to treat erectile dysfunction or premature ejaculation, including other PDE5 inhibitors or selective serotonin reuptake inhibitors (SSRIs). Combining these medications can increase the risk of side effects and adverse reactions.
It's important to note that this list is not exhaustive, and there may be other contraindications or precautions for the use of Extra Super Zhewitra. Individuals considering using this medication should consult with their healthcare provider to discuss their medical history and any potential risks or concerns before starting treatment. Your healthcare provider can provide personalized guidance and recommendations based on your individual circumstances.